Effect of the levonorgestrel-releasing intrauterine system on uterine myomas in a renal transplant patient

The levonorgestrel-releasing intrauterine system (LNG-IUS) has been used in the treatment of both idiopathic menorrhagia and adenomyosis. An electronic search of the on-line medical literature revealed no reports of its use for menorrhagia secondary to uterine myomas. Presented here is the successfu...

Full description

Saved in:
Bibliographic Details
Published in:Contraception (Stoneham) 1999-07, Vol.60 (1), p.51-53
Main Authors: Fong, Yoke-Fai, Singh, Kuldip
Format: Article
Language:English
Subjects:
Adult
Biological and medical sciences
Blood Transfusion
Contraceptive Agents, Female - administration & dosage
Dysmenorrhea - drug therapy
Female
Hematinics - therapeutic use
Hemoglobins - analysis
Hormones. Endocrine system
Humans
Intrauterine Devices, Medicated
Kidney Transplantation - physiology
Leiomyoma - drug therapy
Leiomyoma - physiopathology
Levonorgestrel - administration & dosage
levonorgestrel-releasing intrauterine system
Medical sciences
menorrhagia
Menorrhagia - drug therapy
myoma
Ovary - diagnostic imaging
Pharmacology. Drug treatments
Population
renal transplant
Ultrasonography
Uterine Neoplasms - drug therapy
Uterine Neoplasms - physiopathology
Uterus - diagnostic imaging
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The levonorgestrel-releasing intrauterine system (LNG-IUS) has been used in the treatment of both idiopathic menorrhagia and adenomyosis. An electronic search of the on-line medical literature revealed no reports of its use for menorrhagia secondary to uterine myomas. Presented here is the successful treatment of uterine myomas with menorrhagia in a woman with a renal transplant. There was a significant reduction in menorrhagia, dysmenorrhea, and uterine and myoma size with the use of the LNG-IUS. We believe that this system provides an alternative to conventional hysterectomy and gonadotrophin-releasing hormonal analog medical treatment for uterine myomas, with a possibly inhibitory effect on myoma growth.
ISSN:0010-7824
1879-0518
DOI:10.1016/S0010-7824(99)00061-X